L-RNA aptamer cyclization and use thereof

US12410432B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12410432-B2
Application numberUS-202117236600-A
CountryUS
Kind codeB2
Filing dateApr 21, 2021
Priority dateApr 21, 2021
Publication dateSep 9, 2025
Grant dateSep 9, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of cyclizing an L-RNA aptamer by modifying the aptamer with a 3′ azide and a 5′ alkyne group and using click chemistry reaction-based method. The cyclized L-RNA aptamers have improved binding properties and favour more in vitro/cell applications. Also disclosed is an L-oligonucleotide aptamer having linked ends.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of linking two terminal ends of oligonucleotide, wherein one of the terminal oligonucleotide ends has a 5′ terminal alkyne; and the other one of the terminal oligonucleotide ends has a 3′ azide residue; comprising the step of: linking the 5′ terminal alkyne to the 3′ azide residue, wherein the oligonucleotide is L-Apt.4-1c comprising the nucleotide sequence of SEQ ID NO: 1. 2. A method of joining two terminal ends of an oligonucleotide as claimed in claim 1 , wherein the step of linking the 5′ terminal alkyne to the 3′ azide residue is carried out in the presence of a catalyst for azide-alkyne cycloaddition. 3. A method of joining two terminal ends of an oligonucleotide as claimed in claim 2 , wherein the catalyst is Cu(I). 4. A method of joining two terminal ends of an oligonucleotide as claimed in claim 3 , wherein the step of providing a catalyst for azide-alkyne cycloaddition comprises: providing Cu in a higher oxidation state; and a reducing agent to reduce the Cu in a higher oxidation state to Cu(I). 5. A method of joining two terminal ends of an oligonucleotide as claimed in claim 4 , wherein the Cu is provided in the form of copper (II) complex with the ligand tris(benzyltriazolylmethyl)amine. 6. A method of joining two terminal ends of an oligonucleotide as claimed in claim 4 , wherein the reducing agent is ascorbic acid or its salt. 7. A method of joining two terminal ends of an oligonucleotide as claimed in claim 4 , wherein the Cu in a higher oxidation state is Cu(II)-TBTA.

Assignees

Inventors

Classifications

  • Aptamers · CPC title

  • having two phosphorus atoms as ring hetero atoms in the same ring · CPC title

  • Five-membered rings · CPC title

  • Closed or circular · CPC title

  • C12N15/115Primary

    Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12410432B2 cover?
A method of cyclizing an L-RNA aptamer by modifying the aptamer with a 3′ azide and a 5′ alkyne group and using click chemistry reaction-based method. The cyclized L-RNA aptamers have improved binding properties and favour more in vitro/cell applications. Also disclosed is an L-oligonucleotide aptamer having linked ends.
Who is the assignee on this patent?
Univ City, Univ City Hong Kong
What technology area does this patent fall under?
Primary CPC classification C12N15/115. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).